semaglutide non responder GLP-1 nonresponders: Up to 1 in 5 people don't lose weight Weight loss medications break the

Clinical trials and post-marketing surveillance have identified an increased risk of cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) in patients taking these medications

Highly recommend!" Celeste "Molly has really helped me make positive changes to my health and the health of my family

Never alter your dosing regimen without professional guidance, as diabetes management requires careful monitoring and individualised care

(Memorial Sloan Kettering Cancer Center) Practical what to do next checklist (home steps that are usually safe) If you have mucus with no red flags: Hydrate: Water and oral rehydration solutions if diarrhea is present

current licensed UK options for weight management include orlistat and semaglutide 2.4 mg (Wegovy) under TA875

Sources: MHRA/EMC SmPC for Ozempic and Wegovy